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ULBPs, Novel MHC Class I–Related Molecules,
Bind to CMV Glycoprotein UL16 and Stimulate
NK Cytotoxicity through the NKG2D Receptor
tions of most of the nonessential viral glycoproteins
remain unknown.
NK cells are also known to play an important role in
controlling CMV infection. Patients with defective NK
cell function have problems with herpesvirus infections
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(Biron et al., 1989), and much evidence supports a role†Department of Immunobiology
for NK cells in limiting murine cytomegalovirus (MCMV)Immunex Corporation
replication (Biron et al., 1999; Farrell et al., 1999). NK51 University Street
cell cytotoxicity is known to be controlled by a complexSeattle, Washington 98101
interplay between inhibitory and stimulatory receptors
expressed on the NK cells and their ligands on target
cells (Long et al., 1997; Lanier, 1998). Important compo-Summary
nents of this control system are NK receptors for MHC
class I antigens (killer inhibitory receptors [KIRs]) thatThe human cytomegalovirus glycoprotein, UL16, binds
inhibit NK cytotoxicity when engaged by MHC class Ito two members of a novel family of molecules, the
expressed on the target cell. These negative signalsULBPs, and to the MHC class I homolog, MICB. The
were thought to be dominant over any stimulatory sig-ULBPs are GPI-linked glycoproteins belonging to the
nals that might be transmitted to the NK cells, so thatextended MHC class I family but are only distantly
cells expressing class I MHC antigens would be pro-related to MICB. The ULBP and MICB molecules are
tected from NK cytotoxicity—the “missing self” hypoth-ligands for the activating receptor, NKG2D/DAP10,
esis (Ljunggren and Karre, 1990). However, it was re-and this interaction is blocked by a soluble form of
cently shown that the nonclassical MHC class I antigens,UL16. The ULBPs stimulate cytokine and chemokine
MICA and MICB, could engage a stimulatory receptorproduction from NK cells, and expression of ULBPs
on NK cells consisting of a heterodimeric complex ofin NK cell–resistant target cells confers susceptibility
NKG2D, a C-type lectin, and DAP10, a cell-surface adap-to NK cell cytotoxicity. Masking of NK cell recognition
tor molecule involved in signal transduction (Houchinsof ULBP or MIC antigens by UL16 provides a potential
et al., 1990; Bauer et al., 1999; Wu et al., 1999). Themechanism by which human cytomegalovirus–infected
activation signal resulting from engagement of NKG2D/cells might evade attack by the immune system.
DAP10 was shown to override an inhibitory signal from
MHC class I binding to KIRs, leading to target lysis
Introduction (Bauer et al., 1999).
While CMV downmodulation of host classical MHC
Human cytomegalovirus (HCMV) is a b herpesvirus that class I antigens might help to protect cells against T
is commonly acquired during childhood, leading to mild cell surveillance, it would theoretically leave them vul-
or inapparent symptoms. The virus persists for the life- nerable to NK-mediated lysis, as the engagement of the
time of the host in a latent state with asymptomatic NK KIRs would be diminished. Two mechanisms can be
episodes of viral shedding. However, in immunocom- envisaged by which CMV could counteract this threat:
promised individuals, such as those with AIDS or bone the virus might encode its own MHC class I–like mole-
marrow transplant recipients, the virus is reactivated cule to engage the KIRs, or it might inhibit the function
and replicates in an uncontrolled manner, leading to of an activating molecule like MICA/B. It was proposed
considerable morbidity and mortality (Britt and Alford, several years ago that the HCMV-encoded MHC class
1996). These observations show that HCMV has learned I homolog, UL18, might provide a decoy function to
to exist in equilibrium with the immune system of the engage KIRs (Fahnestock et al., 1995). Expression clon-
normal host and has evolved mechanisms by which to ing of the receptor for UL18 revealed a novel inhibitory
counteract or evade immune surveillance. The genome receptor that also bound cellular MHC class I (leukocyte
of HCMV is large and encodes a number of glycoproteins immunoglobulin-like receptor-1 [LIR-1]) (Cosman et al.,
that are nonessential for virus replication in cell culture. 1997). However, LIR-1 is only expressed on some sub-
Candidate functions for such molecules might be to sets of NK cells and is more widely expressed on my-
allow the virus to infect or replicate in different cell types eloid and B cells (Cosman et al., 1997). Functional exper-
in vivo or as immunomodulators. Recent work has iments designed to support the role of UL18 as an
shown that several of these glycoproteins function inhibitor of NK cell cytotoxicity have provided contradic-
through diverse mechanisms to downregulate MHC tory results (Reyburn et al., 1997; Leong et al., 1998),
and the actual function of UL18 remains controversialclass I expression on infected cells, providing an escape
(reviewed in Cosman et al., 1999). In this paper, we showmechanism from T cell surveillance (Yewdell and Ben-
that another HCMV-encoded glycoprotein, UL16, bindsnink, 1999; Tortorella et al., 2000). However, the func-
to MICB and to two members of a novel family of MHC
class I–related molecules, the ULBPs. The ULBPs and‡ To whom correspondence should be addressed (e-mail: cosman@
the MICs share the property of binding to the NKG2D/immunex.com).
DAP10 receptor and provide a positive signal for NK§ Present address: Target Quest B.V., Provisorium, P.O. Box 5800,
6202 AZ Maastricht, The Netherlands. cell activation and cytotoxicity that can override the
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negative signal mediated by MHC class I/KIR engage-
ment. Recombinant soluble forms of the ULBPs can
bind to NK cells and induce cytokine and chemokine
production. Binding and function of these two ULBPs
is blocked by a soluble form of UL16. These findings
suggest another possible mechanism: inhibition of an
NK cell activation signal, by which a CMV-encoded pro-
tein might inhibit a cytolytic response of the innate im-
mune system.
Results
Isolation of UL16 Binding Proteins
The protein encoded by the HCMV ORF, UL16, was
chosen as a candidate immunomodulator because it is
predicted to be a type 1 membrane glycoprotein and
is known to be expressed by CMV-infected cells but is
undetectable on virions. It is also known to be nonessen-
tial for CMV replication in tissue culture (Kaye et al.,
1992). In order to identify cellular proteins with which
UL16 might interact, a fusion protein was constructed
in which the extracellular domain of UL16 was joined to
the Fc region of human IgG1 (UL16-Fc). This protein
was purified from supernatants of transiently trans-
fected cells and used in flow cytometry experiments
with various cell lines. UL16-Fc was found to bind specif-
ically to HSB2, a human T cell line (data not shown). In
order to identify the UL16 counterstructure on these
cells, an HSB2 cDNA library in a mammalian expression
vector was transfected into CV-1/EBNA cells and
screened for UL16-Fc binding. A single cDNA was identi-
fied that conferred UL16-Fc binding on transfected cells.
The protein sequence encoded by this cDNA matched
that of MICB, also known as PERB11, originally identi-
fied during genomic analysis of the major histocompati-
bility complex (MHC) (Bahram et al., 1994; Leelayuwat
et al., 1994). MICB and the closely related MICA protein
are nonclassical MHC class I antigens that are highly
polymorphic. They have the same basic structure as
classical MHC class I antigens, namely a1, a2, and a3
domains in the extracellular region, a transmembrane
domain, and a short cytoplasmic domain, but, unlike
classical MHC class I molecules, they do not associate
with b2-microglobulin (b2m) or require b2m to be ex-
pressed on the cell surface (Groh et al., 1996).
In a similar series of experiments, UL16-Fc was also
found to bind to Namalwa, a human Burkitt’s lymphoma
line (data not shown). Expression cloning from a Na-
Figure 1. Amino Acid Sequence Comparisons of the ULBPs withmalwa cDNA library resulted in the isolation of a second
Other Extended MHC Class I Family MembersUL16 binding protein. This molecule, ULBP1 (UL16 bind-
(A) Amino acid sequence alignment of the ULBPs. Domains of theing protein), is a previously unidentified protein, distantly
proteins are shown based on exon structures predicted from geno-
related to various members of the extended MHC class mic sequence (data not shown). Potential N-linked glycosylation
I family. Its sequence predicts a1 and a2 domains but sites are indicated in bold. Sequences of the ULBPs have been
no a3 domain. Instead of a transmembrane domain, the deposited with GenBank (accession numbers AF304377-AF304379).
(B) Percent amino acid identities between the ULBPs and selectedsequence predicts a glycosylphosphatidylinositol (GPI)
members of the extended MHC class I family.linkage to the membrane (Figure 1A). Using the se-
(C) Amino acid sequence alignment of the a1 and a2 domains ofquence of ULBP1, two similar sequences were identified
the ULBPs and selected members of the extended MHC class I
in public EST databases. Resequencing of these clones family. Asterisks mark those residues conserved in six or more of
showed that they encoded two ULBP1-related proteins the eight sequences. Bold and underlined amino acids in the HLA-
that we call ULBP2 and ULBP3. The predicted domain A2 sequence represent some key residues for peptide binding, as
discussed in the text.structure of these proteins is similar to ULBP1 (Figure
1A). The amino acid sequences of the three ULBPs are
55%–60% identical; however, the ULBPs show only low
A Family of MHC Class I–Related Ligands for NKG2D
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surprisingly, while the MICB, ULBP1, and ULBP2 Fc
fusion proteins bound strongly to UL16, the closely re-
lated MICA and ULBP3 fusions showed no detectable
binding above the negative controls. In order to deter-
mine if this result might be an artifact of expressing the
MICs and ULBPs in soluble form, binding of UL16-Fc
was tested to cells transfected with full-length ULBPs
and MICs. The results (data not shown) were completely
consistent in that UL16-Fc bound to ULBP1, ULBP2,
and MICB, but not to ULBP3 or MICA.
The ULBP Molecules Are GPI-Linked Proteins
The sequence of the ULBP proteins predicts that they
would be expressed on the cell surface and associated
to the membrane by a GPI linkage. In order to test this,
cells expressing the transiently transfected ULBP mole-
cules were treated with phophatidylinositol-specific
phospholipase C (PI-PLC), and cell-surface expression
of the proteins was assessed using monoclonal antibod-
ies specific for each of the molecules. Compared to cells
undergoing a mock enzyme treatment, expression levels
of ULBP1, ULBP2, and ULBP3 were significantly re-
duced by PI-PLC treatment, as was expression of
LERK4 (ephrin-A4), a molecule known to be GPI linked
(Figure 2B) (Kozlosky et al., 1995). Expression of two
type 1 transmembrane proteins, LERK2 (ephrin-B1) and
MICB, was not altered by PI-PLC treatment, demonstrat-
ing that the ULBPs are indeed GPI-linked, cell-surface
molecules.Figure 2. ULBP and MIC Binding to UL16 and GPI-Linked, Cell-
Surface Expression of ULBPs
Expression of the ULBPs in Cells and Tissues(A) 293 cells transfected with UL16 were stained with MICA-Fc,
MICB-Fc, ULBP1-Fc, ULBP2-Fc, ULBP3-Fc, or a control-Fc (10 mg/ In order to rapidly survey the expression of the ULBPs
ml), followed by PE-conjugated F(ab9)2 goat anti-human IgG (Fc in different cell types, a set of primers was designed
specific). Mean fluorescence intensity values shown are representa- that would detect all three ULBP transcripts in RT-PCR
tive of three independent experiments. Mean fluorescence intensity
experiments. As shown in Figure 3A, expression of ULBPvalues for binding of the above Fc proteins, in the order shown in
transcripts was detected in a variety of cells and tissues.the figure, to 293 cells transfected with vector alone are as follows:
Amplification products of the expected size were not4, 7, 4, 5, 4, 4, and 7.
(B) CV-1 cells transfected with cDNAs encoding the full-length detected when genomic DNA was used as the template
ULBP1, ULBP2, ULBP3, LERK4 (positive control), LERK2, and MICB (data not shown), demonstrating that the experiment
(negative controls) were mock treated (black bars) or treated with was measuring ULBP RNA only. ULBP messages were
PI-PLC (gray bars). Subsequently, cells were stained with specific
detected in T, B, and erythroleukemia cell lines and inmonoclonal antibodies, followed by PE-conjugated sheep anti-
a wide range of tissues including heart, brain, lung, liver,mouse IgG. Mean fluorescence intensity values were calculated
testis, lymph node, thymus, tonsil, and bone marrow.after subtraction of background staining values obtained with the
second step reagent alone. ULBP transcripts were also abundant in fetal heart,
brain, lung, and liver. Since MICA and MICB are ex-
pressed on various epithelial tumor cells and have beenhomology (23%–26% identity) to the MIC proteins, or
postulated to play a role in immune responses againstindeed to other members of the MHC class I family
tumors (Groh et al., 1999), we asked whether ULBP ex-(Figure 1B). Alignment of the sequences of the ULBPs
pression was upregulated in various tumor tissues. Al-and the MICs with those of representative classical and
though we did not perform a quantitative RT-PCR analy-nonclassical MHC class I molecules (Figure 1C) shows
sis, the data in Figure 3A show that, compared tothe presence of z20% highly conserved residues
matched normal tissues, ULBP messages are upregu-throughout the a1 and a2 domains, which clearly identify
lated in colon and stomach tumors but downregulatedthe ULBPs as novel members of the extended MHC
in a kidney tumor. Further studies are required to deter-class I family.
mine whether ULBPs may be involved in tumor recog-
nition.UL16 Binding of MIC and ULBP Molecules
RT-PCR products from various cell lines were di-In order to compare the binding of all the MIC and ULBP
gested with restriction enzymes selected to distinguishproteins to UL16, a series of fusion proteins was con-
ULBP1 and ULBP2 transcripts. We found that ULBP1structed in which the extracellular domains of the ULBPs
and ULBP2 transcripts are coexpressed in all of the celland MICs were joined to the Fc region of human IgG1.
lines tested, with the exception of the Namalwa Burkitt’sThese proteins were expressed, purified, and tested for
lymphoma line in which little or no ULBP2 message wasbinding to full-length UL16 expressed on the cell surface
of transfected CV-1/EBNA cells (Figure 2A). Somewhat detected (Figure 3B). In order to determine if cell-surface
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Figure 3. ULBPs Are Expressed in a Variety
of Cells and Tissues
(A) Various cell lines, tissues, fetal tissues,
and matched normal versus tumor tissues
were analyzed for ULBP message expression
by RT-PCR followed by Southern blotting
with a 32P-labeled ULBP specific cDNA probe
(upper panels). The RT-PCR primers were de-
generate for the amplification of a 322–328
bp region in ULBP1, ULBP2, and ULBP3 (cor-
responding to the major hybridizing band in
each lane). The integrity of the cDNAs was
evaluated by PCR by using HPRT, G3PDH,
or S9 ribosomal protein primers as indicated
to generate PCR products of the expected
size (lower panels). In several tissues, most
notably lung and tonsil, an additional ULBP-
related band of slightly larger size was de-
tected. This may represent a ULBP splice
variant or a related transcript. The results are
representative of two independent experi-
ments.
(B) RT-PCR products from selected cell lines
were digested with BamHI or BglII restriction
enzymes in order to distinguish ULBP1 and
ULBP2 transcripts, respectively. Positive
control digests of PCR products amplified
from ULBP1 or ULBP2 containing plasmids
are shown on the left. The data are represen-
tative of three independent experiments. The
quantities of the PCR products were normal-
ized before digestion.
(C) ULBP cell-surface expression on various
cell lines (Molt-4, CCRF-CEM, Namalwa, Raji,
MP-1, and K562) was analyzed by flow cy-
tometry. The cells were stained with mono-
clonal antibodies specific for ULBP1 (black
line), ULBP2 (solid gray), or ULBP3 (solid stip-
ple), or with an anti-I-309 IgG1 isotype control
antibody (solid black) followed by a biotinyl-
ated goat anti-mouse IgG F(ab9)2 s step and
then streptavidin-PE. The results are repre-
sentative of three independent experiments.
expression of the molecules correlated with mRNA ex- producible binding was seen to primary NK cells (Kubin
et al., submitted). As shown in Figure 4A, all three ULBPpression, selected cell lines were analyzed by flow cy-
tometry using monoclonal antibodies specific for the and both MIC proteins bound specifically to NKL cells,
a cell line derived from a natural killer cell leukemiaULBP proteins. Although in general ULBP protein ex-
pression correlated with ULBP message expression, (Robertson et al., 1996), compared to the binding of a
control Fc fusion protein. To confirm the specificity ofsome obvious discrepancies were found. For example,
in Raji cells ULBP message expression was relatively binding of the Fc fusion proteins, differently tagged solu-
ble ULBPs and MICs were constructed in which theirhigh (Figure 3A), whereas ULBP protein expression was
relatively low (Figure 3C). Thus, ULBP mRNA expression extracellular domains were fused at their C termini to a
modified leucine zipper motif with a hexahistidine tagmay not always predict protein expression. ULBP3 ex-
pression was highest on two of the three B-lineage cell to facilitate purification. This modified leucine zipper has
been shown to form a trimeric structure and to causelines tested. As of yet, we cannot rule out the possibilities
that our monoclonal antibodies might not detect certain the formation of trimeric or higher order multimers when
fused to heterologous proteins (Harbury et al., 1993;ULBP allelic variants or might cross-react with related
proteins. Morris et al., 1999). In each case, the leucine zipper
(LZ) form of a given ULBP or MIC protein was able to
compete the binding of the equivalent Fc fusion proteinBinding of Soluble ULBPs to NK Cells
The ULBP and MIC Fc fusion proteins were tested for to cells (data not shown).
A leucine zipper-tagged form of the extracellular do-their binding to various primary cells and cell lines. Re-
A Family of MHC Class I–Related Ligands for NKG2D
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Figure 4. ULBP and MIC Binding to NKL Cells Is Blocked by
Figure 5. ULBP1, ULBP2, ULBP3, MICA, and MICB Are Ligands forUL16-LZ
NKG2D/DAP10
(A) NKL cells were bound with ULBP-Fcs, MIC-Fcs, or a control-Fc
(A) 293 cells were transfected with cDNAs encoding NGK2D, DAP10,(10 mg/ml), followed by PE-conjugated goat anti-human IgG. Mean
NKG2D 1 DAP10, or vector alone. Transfected cells were stainedfluorescence intensity values shown are representative of five inde-
with MICA-Fc, MICB-Fc, ULBP1-Fc, ULBP2-Fc, ULBP3-Fc, or con-pendent experiments.
trol-Fc (10 mg/ml) followed by PE-conjugated F(ab9)2 goat anti-human(B) ULBP1-Fc (10 mg/ml) was preincubated in the presence or ab-
IgG (Fc specific) and with the M1 mAb (anti-FLAG) (10 mg/ml) fol-sence of UL16-LZ or a CD40L-LZ control protein (250 mg/ml) and
lowed by PE-conjugated sheep anti-mouse IgG. The results shownthen added to NKL cells. Binding was detected using a PE-conju-
are representative of three independent experiments.gated F(ab9)2 fragment goat anti-human IgG, Fc-specific reagent.
(B) NKL cells were preincubated in the presence of 10 ml of poly-Histograms displaying the fluorescence of live cells are presented.
clonal murine anti-NKG2D antiserum or 10 ml of a control antiserumThe results shown are representative of five independent experi-
in a total volume of 100 ml. Cells were then incubated with ULBP1-ments.
Fc (10 mg/ml) followed by PE-conjugated F(ab9)2 goat anti-human
IgG (Fc specific). Histograms displaying the fluorescence of live
main of UL16 was also constructed. Figure 4B shows cells are presented. The results shown are representative of two
that a 10-fold excess of UL16-LZ completely competed independent experiments.
binding of ULBP1-Fc to NKL cells, demonstrating that
UL16 binds to the same (or overlapping) epitopes that
odimers, we tested the binding of the ULBP-Fc fusionULBP1 uses to bind to its cell-surface receptor and
proteins to 293 cells transiently transfected with NKG2Dthat UL16 is a potential inhibitor of the biological activity
and DAP10 expression plasmids. The DAP10 proteinof ULBP1. UL16-LZ was also able to block binding of
was modified by the addition of an N-terminal Flag tagULBP2-Fc and MICB-Fc, but not ULBP3-Fc or MICA-
to allow cell-surface expression to be detected. AsFc, to NKL cells (data not shown), as expected from the
shown in Figure 5A, transfection of DAP10 alone or to-results shown in Figure 2A.
gether with NKG2D allowed detection of the Flag epi-
tope on the cell surface. In contrast, no binding of theBinding of ULBPs to Recombinantly Expressed
ULBP or MIC-Fc proteins was seen to cells transfectedNKG2D/DAP10
with DAP10 alone or NKG2D alone, showing that NKG2DBecause the cell-surface receptors for MICA and MICB
were recently shown to consist of NKG2D/DAP10 heter- requires DAP10 for cell-surface expression. All the ULBP
Immunity
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were seen with ULBP1-LZ and ULBP3-LZ (data not
shown).
Activation of NK Cytotoxicity by the ULBPs
It was previously shown that MICA could overcome an
MHC class I–mediated inhibitory signal and trigger NK
cytotoxicity when expressed on a target cell (Bauer et
al., 1999). In order to test if the ULBP molecules would
function similarly, Daudi cells, which do not express
cell-surface MHC class I due to a mutation in b2m, were
transduced with a retroviral vector encoding wild-type
b2m in order to restore MHC class I expression. The
MHC class I–expressing Daudi cells were then further
transduced with retroviral vectors encoding full-length
Figure 6. ULBPs Induce Cytokine and Chemokine Production by ULBPs or MICA. Cell populations expressing the trans-
NK Cells duced cell-surface molecules were obtained as de-
Purified NK cells were stimulated with IL-15 (50 ng/ml) for 20 hr, scribed in Experimental Procedures. As shown in Figure
washed, and stimulated for an additional 24 hr with ULBP2-LZ (1 7A, MHC class I–negative Daudi cells were efficiently
mg/ml) or a CD40L-LZ control protein (1 mg/ml) in the presence or
killed, whereas b2m-mediated reexpression of cell-sur-absence of IL-12 (1 ng/ml). Supernatants were analyzed for the
face MHC class I afforded protection against NK cyto-presence of GM-CSF, TNF-b, and I-309 proteins as described in
Experimental Procedures. Results shown are representative of three toxicity. This protection was substantially reversed by
experiments performed on cells from different donors. Fab fragments of an antibody directed against MHC
class I molecules (Figure 7B). Introduction of any of the
ULBP or MIC molecules into the MHC class I–expressing
and MIC-Fc fusion proteins bound specifically to cells Daudi cells overcame the MHC class I–induced protec-
transfected with both NKG2D and DAP10, compared to tion and allowed efficient killing by the effector cells
background binding seen with a control Fc fusion pro- (Figure 7A). The specificity of this stimulation of cytotox-
tein. This result suggests that at least a component of icity was demonstrated by using a Fab fragment of a
the ULBP and MIC receptors detected on NK cells is monoclonal antibody against ULBP1 to restore protec-
probably NKG2D/DAP10, as this receptor is known to tion against killing (Figure 7C). These experiments dem-
be expressed by all NK cells (Bauer et al., 1999). onstrate that the ULBPs and MICs function to transduce
An antiserum was raised against a recombinant a dominant stimulatory signal to NK cells, overcoming
NKG2D-Fc fusion protein and tested for its ability to an inhibitory signal generated by MHC class I engage-
block binding of the ULBP and MIC-Fc fusion proteins ment of KIRs.
to NKL cells. The results (Figure 5B) show that the anti-
NKG2D antiserum effectively blocked binding of the Discussion
ULBP1-Fc protein to NKL cells. An antiserum raised
against an irrelevant Fc fusion protein had no effect. The results presented here represent another example
The anti-NKG2D antiserum also blocked binding of all of the use of viral proteins as probes to identify novel
other ULBP and MIC Fc fusion proteins to NKL cells cellular antigens and to investigate the complexities of
(data not shown). This result confirms that NKG2D is an virus-host interactions. The discovery of the ULBP mole-
essential component of the MIC and ULBP receptors on cules followed a similar path to that previously taken to
NK cells but does not rule out the existence of additional identify LIR-1, the receptor for the HCMV-encoded MHC
receptor subunits. class I homolog, UL18 (Cosman et al., 1997), and VESPR,
the receptor for the poxvirus-encoded semaphorin ho-
molog, A39R (Comeau et al., 1998). Unlike many virus-Biological Activity of ULBPs on NK Cells
The presence of receptors for the ULBPs on NK cells encoded immunomodulatory molecules, UL16 has no
detectable homology to any cellular protein, and itsprompted an examination of the biological conse-
quences of binding to these cells. In order to avoid any binding to MICB and the ULBPs could not have been
predicted. Similarly, the poxvirus-encoded soluble che-possible interactions with Fc receptors on the target
cells, the ULBP-LZ fusion proteins were used in these mokine binding protein, p35, shows no homology to
cellular chemokine receptors (Smith et al., 1997), sug-experiments. The NK cells were stimulated overnight
with IL-15 to maximize binding of the ULBPs (Kubin et gesting that viruses can evolve proteins with novel func-
tions by mechanisms other than acquiring cellular genesal., submitted) and then stimulated with the ULBP2-LZ
protein, either alone or with the addition of IL-12, a with similar properties.
It is interesting that UL16 only binds to ULBP1, ULBP2,known stimulus for NK cell cytokine production. Super-
natants from the stimulated NK cells were analyzed for and MICB, but not to the closely related molecules,
ULBP3 and MICA. This finding might suggest that therecytokine and chemokine production. As shown in Figure
6, ULBP2-LZ stimulated production of GM-CSF, TNF-b are distinct biological roles for the different ULBPs and
MICs. We have tested two alleles of MICB but only one(lymphotoxin-a), and the CC chemokine I-309 (a ligand
for CCR8), whereas IL-12 alone had little effect. The allele of MICA for UL16 binding, so it is possible that
other MIC alleles might show different properties. An-combination of IL-12 and ULBP2-LZ had a superadditive
effect on GM-CSF and TNF-b production and a strong other possibility is that there might be strain to strain
variation in UL16 sequences resulting in changes in thesynergistic effect on I-309 production. Similar results
A Family of MHC Class I–Related Ligands for NKG2D
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spectrum of ULBPs and MICs that are bound. In this
respect, the MIC genes show extensive polymorphism
(Bahram et al., 1994; Leelayuwat et al., 1994; Fodil et
al., 1996; Ando et al., 1997) that might be driven by
interaction with a rapidly evolving microbial antigen.
Polymorphism in the ULBP genes has not yet been ex-
amined.
Relationship of the ULBPs to the Extended
MHC Class I Superfamily
The ULBPs are unusual members of the extended MHC
class I superfamily in several respects. They do not
contain the a3 domain that associates with b2m in many
of the classical and nonclassical MHC class I molecules.
Unlike most members of the family, they lack a trans-
membrane domain and use a GPI linkage to the cell
surface. The ULBP genes are not located in the MHC
but instead map to chromosome 6q25 (data not shown).
However, the sequence alignments (Figure 1C) clearly
show that the ULBPs belong to the MHC class I family.
The classical MHC class I molecules, and some other
family members, bind peptides in a cleft formed by the
structure of the a1 and a2 domains. Important contacts
for hydrogen bonding to the N termini of the bound
peptides are the conserved tyrosine residues at posi-
tions 7, 59, 159, and 171 of the classical MHC class I
molecules (Matsumura et al., 1992). All but the equiva-
lent of tyrosine 7 are absent from the ULBP sequences
(Figure 1C). At the binding site for the C termini of dis-
played peptides are the conserved residues, Y84, T143,
K146, and W147, that also form hydrogen bonds and a
salt bridge with the peptide (Matsumura et al., 1992).
Only the equivalents of K146 and W147 are found in the
ULBP sequences. Taken together, the absence of so
many conserved amino acids that are known to be im-
portant for peptide binding by classical MHC class I
molecules suggests that the ULBPs are unlikely to pre-
sent peptides.
Relationship of the ULBPs to Other NKG2D Ligands
Although the ULBPs and the MIC proteins bind to the
NKG2D/DAP10 complex, the ULBP sequences are no
more closely related to the MIC sequences than to any
other members of the extended MHC class I family (Fig-
ure 1B). During the preparation of this manuscript, a
Figure 7. NK Cell Killing of MHC Class I1 Daudi Target Cells Is number of mouse ligands for NKG2D/DAP10, the RAE-1
Restored by Transduction of MICA, ULBP1, ULBP2, or ULBP3 family and H60 proteins, were identified (Cerwenka et al.,
Daudi cells were transduced with amphotropic retroviruses encod- 2000; Diefenbach et al., 2000). Interestingly, the overall
ing b2m. The MHC class I1, b2m transduced cells were further trans- structure of these proteins resembles the ULBPs rather
duced with retroviruses encoding MICA, ULBP1, ULBP2, or ULBP3. than the MICs in that they contain only a1 and a2 do-
Transduced cells were enriched by panning on magnetic beads
mains. The RAE-1 proteins are GPI linked whereas H60coated with monoclonal antibodies specific for each molecule and
appears to be a transmembrane protein. However, thefurther enriched by fluorescence activated cell sorting for uniform
expression of the transduced proteins. When stained with specific
monoclonal antibodies, the following MFIs were measured on the
target cells: Class I1 Daudi – MHC class I 5 3500; Class I1/MICA1
Daudi – MHC class I 5 2300 and MICA 5 2100; Class I1/ULBP11 (B) Class I1 Daudi targets were preincubated with the W6/32 (anti-
Daudi – MHC class I 5 3700 and ULBP1 5 120; Class I1/ULBP21 Daudi– MHC class I) Fab, a control Fab (50 mg/ 0.5 3 106 targets), or in the
MHC class I 5 3000 and ULBP2 5 150; Class I1/ULBP31 Daudi – absence of Fab, before addition to effector cells.
MHC class I 5 3500 and ULBP3 5 200. The MFIs for non-transduced (C) Class I1/ULBP11 Daudi targets were preincubated with the M291
Daudi cells were: MHC class I 5 15, MICA 5 8, ULBP1 5 22, ULBP2 5 (anti-ULBP1) Fab, a control Fab (50 mg/0.5 3 106 targets), or in the
14, ULBP3 5 6. 3 hr 51Cr-release assays were performed using IL-15 absence of Fab, before addition to effector cells.
activated NK cells from human donors at the indicated effector to Individual data points are calculated from the averages of triplicate
target ratios. samples. The results shown are from a single donor but are repre-
(A) The following cell lines were used as targets: Daudi, Class I1 sentative of seven independent experiments done on a total of four
Daudi, Class I1/MICA1 Daudi, Class I1/ULBP11 Daudi, Class I1/ separate donors (A) or three independent experiments done on a
ULBP21 Daudi, and Class I1/ULBP31 Daudi. total of two separate donors (B) and (C).
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RAE-1 and H60 sequences show only 22%–24% amino NKG2D ligands have been suggested to be more preva-
lent on transformed cells (Cerwenka et al., 2000; Diefen-acid identity to the ULBP sequences, suggesting that
the NKG2D/DAP10 complex is capable of binding a bach et al., 2000). Although the data presented here
show no consistent increase of ULBP mRNA levels innumber of ligands of diverse sequence. There are very
few residues conserved between the proteins capable tumor cells compared to normal tissue, this issue re-
quires further investigation at the level of ULBP proteinof binding NKG2D/DAP10 that are not also conserved
in the extended MHC class I family (data not shown). expression. It is also possible that the ULBPs may act
in concert with other target cell antigens to activateMore extensive structural analysis will be required to
determine if all the NKG2D/DAP10 ligands bind in the immune effector cells.
same way. Given the low sequence identities between
the RAE-1 and H60 proteins and the ULBPs, it is difficult Possible Mechanism of Immune Evasion by UL16
to assert that these are the true species homologs of the We have presented evidence that the interaction be-
ULBPs. Evidence has been presented that expression of tween ULBPs and their receptor on NK cells can be
the RAE-1s and H60 is higher in transformed cell lines blocked by a soluble form of UL16. Data presented
than in normal tissues (Cerwenka et al., 2000; Diefen- elsewhere (Kubin et al., submitted) also demonstrate
bach et al., 2000). However, direct comparison of ULBP blocking of ULBP-mediated biological activities by solu-
mRNA levels in several matched normal and tumor tis- ble forms of UL16. Extrapolation from these results to
sue samples shows no consistent difference in expres- what might occur in the context of a CMV infection leads
sion (Figure 3A). H60 expression was induced upon acti- to the hypothesis that UL16 could mask the recognition
vation of mouse splenocytes (Diefenbach et al., 2000), of ULBPs or MICB by NKG2D-expressing cells and thus
but we have been unable to detect ULBP surface ex- prevent the activation of these cells to kill virus-infected
pression on activated human peripheral blood mononu- targets and to secrete increased amounts of cytokines
clear cells (data not shown). It therefore remains to be and chemokines. UL16 expression on the surface of the
determined if true mouse homologs of the ULBPs exist. infected cell might lead to the formation of a complex
There is precedent for a lack of conservation of immune with ULBPs or MICB; alternatively, UL16 binding might
recognition molecules between mouse and human; de- retain ULBPs or MICB within the infected cell. Whether
spite much effort, human homologs of the mouse Ly49 infection by HCMV or other pathogens might induce
family and mouse homologs of the human killer cell expression of NKG2D ligands is also of interest, as it
immunoglobulin-like receptors (KIRs) have yet to be would provide a potential mechanism by which NK cells
identified (Lopez-Botet et al., 2000). could recognize and kill infected cells even in the ab-
sence of MHC class I antigen downregulation. Further
Possible Functions of ULBPs in Immune investigation of these issues may provide additional in-
Responses to Viruses and Tumors sight into how HCMV can maintain a lifelong relationship
Binding of ULBP proteins to NK cells triggers production with its host and add to our knowledge of the controls
of multiple cytokines and chemokines. These include that exist to enable cells of the innate immune system
LTa/TNFb, GM-CSF, and I-309 (this paper) and TNFa, to distinguish self from infected, “stressed,” or trans-
IFNg, and MIP-1b (Kubin et al., submitted). In all cases, formed self.
IL-12 enhances production of these factors, although
Experimental Proceduresthe magnitude of this enhancement varies. In vivo, these
cytokines and chemokines are likely to contribute to the
Cell Lines and Purification of Cellsrecruitment and activation of NK cells, macrophages,
Daudi, Raji, and Namalwa, Burkitt’s lymphoma cell lines (ATCC CRL-
and other cellular components of the innate and adap- 213, ATCC CCL 86, and ATCC CRL 1432, respectively), Molt-4, a T
tive immune response. TNFa and IFNg are known to be cell leukemia (ATCC CRL 1582), CCRF-CEM, a T lymphoblastoid
cell line (ATCC CCL 119), MP-1, a B lymphoblastoid cell line, andimportant antiviral cytokines, acting directly and indi-
K562, an erythroleukemia cell line (ATCC CCL 243), were all grownrectly against virus-infected cells (Biron et al., 1999).
in RPMI-1640 supplemented with 10% fetal calf serum (FCS). TheExpression of ULBP proteins in cells that are relatively
human NK cell line NKL was a generous gift from Dr. Michael J.resistant to NK cell cytotoxicity (MHC class I–expressing
Robertson and was cultured as described (Robertson et al., 1996).
Daudi cells) generates potent activation of killing. To- Short-term cultured primary human NK cells were obtained as de-
gether, these data argue for an important role of the scribed (Perussia et al., 1987) and purified by magnetic negative
selection using a MACS column (Miltenyi Biotec, Auburn, CA) asULBPs, like the MICs, in activation of innate immune
described (Cosman et al., 1997). Primary NK cells were culturedresponses. It remains to be determined how ULBP ex-
overnight in the presence of 50 ng/ml rhuIL-15 (Immunex). 293EBNApression and/or activation is controlled under physiolog-
(Invitrogen) and CV-1/EBNA were grown and transfected as pre-ical and pathological circumstances.
viously described (McMahan et al., 1991).
NKG2D has been shown to be expressed by gd T
cells, CD81 T cells, and activated macrophages, as well Construction and Expression of Fc Fusion Protein Constructs
as NK cells (Yabe et al., 1993; Bauer et al., 1999; Diefen- All Fc fusion proteins contain the extracellular domain of the protein
of interest fused to the amino terminus of the hinge region of abach et al., 2000). In addition to their roles in innate and
modified human IgG1 Fc region (Baum et al., 1994) and were thenadaptive immune responses to infections, these cells
subcloned into the mammalian expression vector pDC409 (Giri etare also believed to mediate antitumor activities. Do the
al., 1994) or pDC412 (the pDC412 vector is identical to pDC409NKG2D ligands play a role in the recognition of tumor
except that the NotI and BglII cloning sites have been transposed).
cells by the immune system? The MIC proteins have The UL16-Fc fusion protein contains the extracellular domain of
been shown to be more highly expressed by tumor cells UL16 fused to the Fc region after amino acid 183. The MICA-Fc
fusion protein contains the extracellular domain of MICA fused tothan by normal cells (Groh et al., 1999), and the mouse
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the Fc region after amino acid 297. The MICA allele used corre- conferred UL16-Fc binding. The HSB2 and Namalwa cDNA libraries
screened were constructed in the mammalian expression vectorsponded to GenBank accession number AAD52060 with the single
exception of a conservative amino acid substitution at position 256 pDC410 as previously described (Kozlosky et al., 1995).
of Val to Ile. The MICB-Fc fusion protein contains the extracellular
domain of MICB fused to the Fc region after amino acid 297. The
Sequence Analysis
MICB allele used corresponded to GenBank accession number
The amino acid sequence of ULBP1 was used to search the Gen-
AAB71643. Another MICB allele corresponding to accession number
Bank dbEST database using the TBLASTN program. The clones
AF021222 also bound to UL16. The ULBP1-Fc fusion protein con-
corresponding to accession numbers R25716 (ULBP2) and AI091180
tains the extracellular region of ULBP1 fused to the Fc region after
(ULBP3) were purchased from Research Genetics and completely
amino acid 220. The ULBP2-Fc fusion protein contains the extracel-
sequenced. The first five amino acids of ULBP3 sequence were
lular region of ULBP2 fused to the Fc region after amino acid 222.
predicted from GenBank high throughput genomic sequence (ac-
The ULBP3-Fc fusion protein contains the Ig k leader sequence
cession number AL138890). Sequence alignments and compari-
fused to the ULBP3 extracellular region at amino acid 23, and the
sons used the Pileup and Gap programs of the Genetics Computer
ULBP3 extracellular region fused to the Fc region at amino acid
Group, Inc.
220. The NKG2D-Fc fusion protein contains the extracellular region
of NKG2D fused to the Fc region at amino acid 74. In this construct,
the NKG2D extracellular region is placed in frame with the COOH Generation of Monoclonal Antibodies
terminus of the Fc region to position it in the proper orientation for a BALB/C mice were immunized at 0, 2, and 6 weeks with 10 mg of the
type II fusion protein. The sequences of the oligonucleotide primers appropriate Fc protein as described (Cosman et al., 1997). Positive
used to amplify the desired sequences by PCR are available upon supernatants were subsequently confirmed by flow cytometry and
request. immunoprecipitation using CV-1 cells transfected with cDNAs en-
Plasmids encoding the Fc fusion proteins were transfected into coding full-length ULBP1, ULBP2, ULBP3, or MICA/MICB. Antibod-
CV-1/EBNA (ATCC CRL-10478) cells, and the fusion proteins were ies were chosen with specific reactivity to the protein used for immu-
purified from culture supernatants by chromatography on a protein nization. Hybridomas were cloned and followed using the same
A-Poros column (PerSeptive Biosystems) as described (Fanslow et assay. Monoclonal cultures were expanded and monoclonal anti-
al., 1992). bodies purified by protein A affinity chromatography (BioRad protein
A control Fc fusion protein, p7.5-Fc, has been previously de- A agarose).
scribed (Yao et al., 1995).
Flow Cytometric Analysis
Construction and Expression of LZ Protein Constructs The following monoclonal antibodies were used for flow cytometric
All LZ fusion proteins contain the extracellular domain of the protein analysis: M1, IgG1 anti-FLAG; M90, anti-hCD40L used as an IgG1
of interest fused to a trimerization domain based upon a leucine isotype control; M5, IgG1 anti-FLAG used as an IgG1 isotype control;
zipper motif (O’Shea et al., 1989) modified to form a trimer (Harbury M230, IgG1 anti-UL16; M291, M293, M294, and M295, IgG1 anti-
et al., 1993) followed by six histidine residues and were then sub- ULBP1; M292, IgG2a anti-ULPB1; M310, M311, and M312, IgG1
cloned into the mammalian expression vector pDC409 or pDC412. anti-ULBP2; M550 and M551, IgG1 anti-ULBP3; M363 and M364,
The UL16-LZ fusion protein contains the extracellular domain of IgG1 anti-MICA/MICB (generated as described above); W6/32,
UL16 fused to the LZ domain after amino acid 187. The MICA-LZ IgG2a pan anti-HLA-A,-B,-C (ATCC HB-95); OKT3, anti-CD3 used
fusion protein contains the extracellular domain of MICA fused to as an IgG2a isotype control (ATCC CRL 8001); MAB272, anti-I-309
the LZ domain after amino acid 297. The ULBP1-LZ fusion protein used as an IgG1 isotype control (R&D Systems).
contains the extracellular region of ULBP1 fused to the LZ domain Cells (5 3 105) were incubated with 1 mg antibody or 1 mg Fc
after amino acid 220. The ULBP2-LZ fusion protein contains the fusion protein for 30 min on ice. Specific binding was detected
extracellular region of ULBP2 fused to the LZ domain after amino with either a PE-conjugated sheep anti-mouse IgG (Sigma), a PE-
acid 222. The ULBP3-LZ fusion protein contains the Ig k leader conjugated F(ab9)2 fragment goat anti-human IgG, Fcg fragment
sequence fused to the ULBP3 extracellular region at amino acid 23 specific (Jackson Immunoresearch), or a combination of a biotin-
and the ULBP3 extracellular region fused to the LZ domain at amino conjugated goat anti-mouse IgG F(ab9)2 followed by PE-conjugated
acid 221. The sequences of the oligonucleotide primers used to streptavidin (Jackson Immunoresearch). In UL16-LZ blocking assays,
amplify the desired sequences by PCR are available upon request. 1 mg of the binding protein was preincubated with 25 mg of the
Plasmids encoding the LZ fusion proteins were transfected into UL16-LZ for 30 min on ice prior to addition to the cells. After staining,
CV-1/EBNA cells, and the fusion proteins were purified from culture cells were analyzed on a Becton Dickinson FACScan.
supernatants using immobilized metal affinity chromatography. Su-
pernatants were passed over an Alltech column packed with Co-
RT-PCR and Southern Expression Analysisbound TALON Superflow resin according to the manufacturer’s
To examine ULBP message expression, degenerate primers (for-specifications (Clontech).
ward primer: 59-CTGCAGGYMAGGATGTCTTGTGAG-39; reverse
primer: 59-T GAGGGTGGTGGCYRTGGC-39) were used to amplify aConstruction of FLAG-DAP10
322 bp region of ULBP1 and ULBP3 and a 328 bp region of ULBP2The DAP10 gene was amplified by PCR using a full-length DAP10
from various cell lines and tissues. Tissue cDNA panels and matchedcDNA as a template (forward primer 59-CTAGTCGAGACTAGTCA
normal and tumor cDNA pairs were purchased from Clontech. TheGACGACTCCAGGAGAGAGATC-39; reverse primer 59-CTAGTCGA
RT-PCR consisted of 32 cycles at 958C for 1 min, 608C for 1 min,GAGATCTGAAGTCAAAGGTCCAAGCTGCAG-39). The amplification
and 728C for 1 min. The amplified PCR products were transferredproduct was digested with SpeI and BglII and ligated into the
to Hybond N1 (Amersham) and probed with a random-primed probepDC409 vector, containing a 59 sequence encoding the FLAG pep-
that was transcribed from a mixture of 322-328 bp ULBP1, ULBP2,tide, cut with SpeI and BglII.
and ULBP3 PCR products as template. To distinguish ULBP1 and
ULBP2 transcripts, RT-PCR products from selected cell lines were
Expression Cloning
digested with BamHI or BglII, respectively.
The procedures used were those previously described (McMahan
et al., 1991; Goodwin et al., 1993). In brief, plasmid DNA from pools
of 2000 cDNA clones were transfected into CV-1/EBNA cells grown Phosphatidyl-Inositol-Specific Phospholipase C Treatment
To obtain evidence for GPI linkage of the ULBP proteins, cells trans-on one-chambered glass slides. Two or three days after transfection,
the cells were incubated with 1 mg/ml of UL16-Fc protein or an fected with cDNAs encoding these proteins were treated with 2 U/ml
phospatidyl-inositol-specific phospholipase C (PI-PLC) (Sigma) atunrelated Fc protein control in binding buffer followed by 125I-Fc-
specific mouse anti-human IgG for 30 min at room temperature. 378C for 1 hr. Subsequently, cells were washed with 1 3 PBS and
stained on ice by indirect immunofluorescence using specific anti-The cells were washed, fixed, and processed for autoradiography.
Positive pools were subdivided until a single clone was obtained that bodies as described above.
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51Chromium Release Assay Baum, P.R., Gayle, R.B., III, Ramsdell, F., Srinivasan, S., Sorensen,
R.A., Watson, M.L., Seldin, M.F., Baker, E., Sutherland, G.R., Clifford,The 51Cr release assay was performed using 104 51Cr-labeled targets
per well. Effectors were added at the indicated concentrations and K.N., et al. (1994). Molecular characterization of murine and human
OX40/OX40 ligand systems: identification of a human OX40 ligandplates were incubated for 2–3 hr at 378C, 5% CO2. The released
radioactivity in the cell-free supernatants was measured with a as the HTLV-1-regulated protein gp34. EMBO J. 13, 3992–4001.
gamma counter (Micromedic). Specific lysis was calculated by the Biron, C.A., Byron, K.S., and Sullivan, J.L. (1989). Severe herpesvirus
standard formula: (experimental 2 spontaneous release)/(total 2 infections in an adolescent without natural killer cells. N. Engl. J.
spontaneous release) 3 100. Med. 320, 1731–1735.
Blocking assays were carried out using Fab fragments of specific
Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P., and Salazar-antibodies or the UL16LZ protein. The generation of Fab fragments
Mather, T.P. (1999). Natural killer cells in antiviral defense: functionof monoclonal antibodies was performed as previously described
and regulation by innate cytokines. Annu. Rev. Immunol. 17,(Goding, 1983). 51Cr-labeled targets (5 3 105) were incubated with
189–220.50 mg of the Fab fragments for 20 min at 378C, washed with media,
Britt, W., and Alford, C. (1996). Cytomegalovirus. In Field’s Virology,and plated at 104 cells per well. Effectors were added and assays
B.N. Field, D.M. Knipe, and P.M. Howley, eds. (Philadelphia: Lippin-carried out as described above.
cott-Raven), pp. 2493–2523.
Chemokine and Cytokine Assays Cerwenka, A., Bakker, A.B., McClanahan, T., Wagner, J., Wu, J.,
Primary human NK cells were treated with IL-15 (50 ng/ml) for 20 Phillips, J.H., and Lanier, L.L. (2000). Retinoic acid early inducible
hr, washed, and then stimulated with the indicated fusion proteins genes define a ligand family for the activating NKG2D receptor in
at 1 mg/ml with or without rhuIL-12 (1 ng/ml) (R&D Systems) for 20 mice. Immunity 12, 721–727.
hr at 378C, 5% CO2. Cytokine and chemokine levels in cell-free Comeau, M.R., Johnson, R., DuBose, R.F., Petersen, M., Gearing,
supernatants were determined by ELISA. GM-CSF levels were deter-
P., VandenBos, T., Park, L., Farrah, T., Buller, R.M., Cohen, J.I., et
mined using the M8 and P5 paired antibodies (Immunex), whereas
al. (1998). A poxvirus-encoded semaphorin induces cytokine pro-
I-309 and TNFb levels were determined using paired antibodies (R&D
duction from monocytes and binds to a novel cellular semaphorin
Systems) according to manufacturer’s specifications. All assays
receptor, VESPR. Immunity 8, 473–482.
were performed in triplicate wells, and results are presented as the
Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson,mean from the given culture conditions.
L., and Hsu, M.L. (1997). A novel immunoglobulin superfamily recep-
tor for cellular and viral MHC class I molecules. Immunity 7, 273–282.Retroviral Constructs and Transduction
Daudi cells were transduced with amphotropic retroviruses gener- Cosman, D., Fanger, N., and Borges, L. (1999). Human cytomegalovi-
ated using the LZRSpBMN-Z vector (Kinsella and Nolan, 1996) in the rus, MHC class I and inhibitory signalling receptors: more questions
Phoenix packaging line (kindly provided by the Nolan lab, Stanford than answers. Immunol. Rev. 168, 177–185.
University). Transduced cells expressing class I, MICA, and the Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N., and Raulet,
ULBP antigens were selected using magnetic beads. Transduced D.H. (2000). Ligands for the murine NKG2D receptor: expression
cells were stained with monoclonal antibodies specific for the anti- by tumor cells and activation of NK cells and macrophages. Nat.
gens of interest followed by PE-conjugated sheep anti-mouse IgG. Immunol. 1, 119–126.
Stained cells were incubated with anti-PE microbeads and passed
Fahnestock, M.L., Johnson, J.L., Feldman, R.M., Neveu, J.M., Lane,over MACS separation columns according to manufacturer’s speci-
W.S., and Bjorkman, P.J. (1995). The MHC class I homolog encodedfications (Miltenyi Biotec). To isolate cell populations expressing
by human cytomegalovirus binds endogenous peptides. Immunityhomogeneous levels of the antigens of interest, these cells were
3, 583–590.further sorted by flow cytometry.
Fanslow, W.C., Anderson, D.M., Grabstein, K.H., Clark, E.A., Cos-
Generation of Polyclonal Murine anti-NKG2D Serum man, D., and Armitage, R.J. (1992). Soluble forms of CD40 inhibit
Balb/c mice were immunized subcutaneously with 10 mg of NKG2D- biologic responses of human B cells. J. Immunol. 149, 655–660.
Fc protein in Titermax (Cytrx) adjuvant. Four weeks after immuniza- Farrell, H.E., Degli-Esposti, M.A., and Davis-Poynter, N.J. (1999).
tion, serum samples were obtained by tail bleed. Cytomegalovirus evasion of natural killer cell responses. Immunol.
Rev. 168, 187–197.
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